MERS-CoV spike protein: a key target for antivirals

L Du, Y Yang, Y Zhou, L Lu, F Li… - Expert opinion on …, 2017 - Taylor & Francis
… Introduction: The continual Middle East respiratory syndrome (MERS) threat highlights the …
treat MERS coronavirus (MERS-CoV) infection. A surface spike (S) protein guides MERS-CoV

Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein

S Xia, Q Liu, Q Wang, Z Sun, S Su, L Du, T Ying, L Lu… - Virus research, 2014 - Elsevier
MERS-CoV infection. Here we discuss the most recent studies on the structure of … MERS-CoV
spike protein and its role in virus binding and entry, and the development of MERS-CoV

MERS-CoV spike protein: targets for vaccines and therapeutics

Q Wang, G Wong, G Lu, J Yan, GF Gao - Antiviral research, 2016 - Elsevier
… The MERS-CoV spike (S) protein is an … of the S protein in the MERS-CoV life cycle, summarize
recent advances in the development of vaccines and therapeutics based on the S protein, …

Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein

H Kleine-Weber, MT Elzayat, M Hoffmann… - Scientific reports, 2018 - nature.com
… novel antiviral strategies to combat MERS. The MERS-CoV spike protein (MERS-S) is inserted
into the viral envelope and mediates viral entry into target cells. For this, MERS-S binds to …

Spiking the MERS-coronavirus receptor

BJ Bosch, VS Raj, BL Haagmans - Cell research, 2013 - nature.com
… the S protein or receptor, which allow MERS-CoV to … protein shown to be critical for DPP4
binding and viral entry. This information is crucial to understand the adaptation of MERS-CoV

MERS coronavirus: an emerging zoonotic virus

F Li, L Du - Viruses, 2019 - mdpi.com
Middle East respiratory syndrome coronavirus (MERS-CoV) is … To date, MERS-CoV continues
to infect humans with a fatality … The MERS-CoV surface spike (S) protein is a key target for …

[HTML][HTML] Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein

J Goo, Y Jeong, YS Park, E Yang, DI Jung, S Rho… - Virus research, 2020 - Elsevier
Middle East Respiratory Syndrome coronavirus (MERS-CoV) causes severe pulmonary
infection, with ∼35 % mortality. Spike glycoprotein (S) of MERS-CoV is a key target for vaccines …

Immunogenicity of candidate MERS-CoV DNA vaccines based on the spike protein

SS Al-Amri, AT Abbas, LA Siddiq, A Alghamdi… - Scientific reports, 2017 - nature.com
… remain over protein or full-length spike (S) protein-based … expressing different fragments of
MERS-CoV S protein in mice. We … S1-subunit of the MERS-CoV S protein could represent a …

A fusion peptide in the spike protein of MERS coronavirus

EAJ Alsaadi, BW Neuman, IM Jones - Viruses, 2019 - mdpi.com
… A key step in the MERS-CoV replication cycle is the fusion of the virus and host cell … by
the virus spike protein, S. The location of the fusion peptide within the MERS S protein has not …

MERS: emergence of a novel human coronavirus

VS Raj, ADME Osterhaus, RAM Fouchier… - Current opinion in …, 2014 - Elsevier
… are involved in binding the MERS-CoV spike protein revealed that these animal species
are more likely able to use DPP4 as a functional receptor for MERS-CoV entry as compared to …